Organization

OUR MISSION

We strive to make prostate cancer diagnosis quicker, more affordable, and less invasive by pairing artificial intelligence technology with ultrasound imaging.

EXECUTIVE MANAGEMENT TEAM

Mark Bloemendaal

CEO
Prof. Dr. ir. Massimo Mischi

Scientific Strategic Advisor
Prof. Dr. ir. Hessel Wijkstra

Clinical Strategic Advisor
Prof. Dr. Harrie Beerlage

Clinical Board Chairman

CLINICAL BOARD

Prof. Dr. Hashim Ahmed

Board Member
Prof. Dr. Chris Bangma

Board Member
Prof. Dr. Harrie Beerlage

Chairman
Prof. Dr. Alberto Briganti

Board Member
Prof. Dr. Daniel Eberli

Board Member
Prof. Dr. Jurgen Fütterer

Board Member
Prof. Dr. Peter Pinto

Board Member
Prof. Dr. Hendrick van Poppel

Board Member
Prof. Dr. Georg Salomon

Board Member
Prof. Dr. Jochen Walz

Board Member